GLP-1 RAs Hold Promising Potential for Reduction of Cardiometabolic Risk Factors additional benefits : Brain: Appetite suppression, nerve protection, and decreased neuroinflammation Heart: Decreased blood pressure (systolic and diastolic), reduced total cholesterol levels, lowered endothelial dysfunction, and increased heart rate Liver: Decreased glucose production Pancreas: Increased insulin secretion, decreased glucagon secretion, B islet cell proliferation GI Tract: Decreased gastric emptying Because these drugs cause weight loss, it is not clear whether the GLP-1 RAs or the weight loss reduces cardiometabolic risks
For information for pregnant women and nursing mothers, please refer to the package insert
a public comment period runs through June 29, 2026
BPC-157 and other research peptides
When this happens, bile can no longer flow normally, potentially leading to inflammation or infection of the gallbladder, a condition called acute cholecystitis
Method and route of administration Intramuscular and oral injectable routes